Your browser doesn't support javascript.
loading
Double Umbilical Cord Blood Transplantation in High-Risk Hematological Patients: A Phase II Study Focusing on the Mechanism of Graft Predominance.
Kalin, Burak; Ter Borg, Mariëtte; Wijers, Rebecca; Somers, Judith A E; van der Holt, Bronno; van Bergen, Cornelis A M; Petersen, Eefke J; Kuball, Jurgen; Meijer, Ellen; Schaap, Nicolaas P M; Zeerleder, Sacha S; Broers, Annoek E; Braakman, Eric; Falkenburg, J H Frederik; Lamers, Cor H J; Cornelissen, Jan J.
Afiliación
  • Kalin B; Erasmus University Medical Center, Department of Hematology, Rotterdam, Netherlands.
  • Ter Borg M; Erasmus University Medical Center, Department of Hematology, Rotterdam, Netherlands.
  • Wijers R; Erasmus MC Cancer Institute, Laboratory of Tumor Immunology, Department of Medical Oncology, Rotterdam, Netherlands.
  • Somers JAE; Erasmus University Medical Center, Department of Hematology, Rotterdam, Netherlands.
  • van der Holt B; Sanquin Blood Supply, Department of Transfusion Medicine, Rotterdam, Netherlands.
  • van Bergen CAM; Erasmus MC Cancer Institute, HOVON Data Center, Department of Hematology, Rotterdam, Netherlands.
  • Petersen EJ; Leiden University Medical Center, Department of Hematology, Leiden, Netherlands.
  • Kuball J; University Medical Center Utrecht, Department of Hematology, Utrecht, Netherlands.
  • Meijer E; University Medical Center Utrecht, Department of Hematology, Utrecht, Netherlands.
  • Schaap NPM; Amsterdam University Medical Center, VU Medical Center, Department of Hematology, Cancer Center Amsterdam, Amsterdam, Netherlands.
  • Zeerleder SS; Radboud University Medical Center, Department of Hematology, Nijmegen.
  • Broers AE; Amsterdam Medical Center, Department of Hematology, Amsterdam, Netherlands.
  • Braakman E; Erasmus University Medical Center, Department of Hematology, Rotterdam, Netherlands.
  • Falkenburg JHF; Erasmus University Medical Center, Department of Hematology, Rotterdam, Netherlands.
  • Lamers CHJ; Leiden University Medical Center, Department of Hematology, Leiden, Netherlands.
  • Cornelissen JJ; Erasmus MC Cancer Institute, Laboratory of Tumor Immunology, Department of Medical Oncology, Rotterdam, Netherlands.
Hemasphere ; 3(4): e285, 2019 10.
Article en En | MEDLINE | ID: mdl-31942540

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Hemasphere Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Etiology_studies / Risk_factors_studies Idioma: En Revista: Hemasphere Año: 2019 Tipo del documento: Article País de afiliación: Países Bajos Pais de publicación: Estados Unidos